CG Bio Acquires Majority Stake in Innosys

CG Bio acquires majority stake in Innosys

CG Bio became the largest shareholder in Innosys, a research and manufacturing company focused on orthopedic implants, following the completion of an equity acquisition.

CG Bio specializes in the integration of biotechnology to develop medical devices, including Novosis bone substitute and the Novomax cervical cage which is based on bioactive...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us